Mara Gilardi (@gilardimara) 's Twitter Profile
Mara Gilardi

@gilardimara

SME in immuno-oncology at Champions Oncology

Cancer immunology; immunotherapy, microfluidics, personalized medicine.

ID: 1365687537197588483

linkhttps://scholar.google.com/citations?user=dLBgNikAAAAJ&hl=en calendar_today27-02-2021 15:38:34

22 Tweet

70 Followers

132 Following

GutkindLab (@silviogutkind) 's Twitter Profile Photo

So happy to share our recent study on multimodal precision immunotherapy! An amazing multidisciplinary team, bringing together precision medicine to immune oncology (Pharmacology2.0) IOTN Moonshot Umamaheswar Duvvuri MD PhD Joseph Califano UCSD Cancer Ezra Cohen Robert S-K

Human Immunology News (@humanimmunenews) 's Twitter Profile Photo

Led by GutkindLab, UCSD Health Moores Cancer Center CRCERA scientists employed an unbiased kinome-wide siRNA screen to reveal that HER3, was essential for the proliferation of most head and neck squamous cell carcinoma cells that did not harbor PIK3CA mutations. Nature Communications: go.nature.com/32RWIpg

Led by <a href="/SilvioGutkind/">GutkindLab</a>, <a href="/UCSDCRCERA/">UCSD Health Moores Cancer Center CRCERA</a> scientists employed an unbiased kinome-wide siRNA screen to reveal that HER3, was essential for the proliferation of most head and neck squamous cell carcinoma cells that did not harbor PIK3CA mutations.

<a href="/NatureComms/">Nature Communications</a>:
go.nature.com/32RWIpg
Mara Gilardi (@gilardimara) 's Twitter Profile Photo

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas mct.aacrjournals.org/content/19/9/1…

Mara Gilardi (@gilardimara) 's Twitter Profile Photo

Proud to share our last amazing paper dissecting cancer cell extravasation with 3D engineered microfluidic models! A productive international collaboration! Thank you to all the authors! Enjoy! Happy to share the technology and collaborate! authors.elsevier.com/c/1dUkxWWN0osWs

Tullia Bruno, PhD (@bcellbruno) 's Twitter Profile Photo

We (Brad Nelson, Dan Hollern, Tullia Bruno, and Marie-Caroline Dieu-Nosjean) have developed a virtual seminar series through our new B cells in Cancer Consortium (BC^3) group. Check out the info and participate! #Bcells #Bcellsincancer Daniel Hollern

We (Brad Nelson, Dan Hollern, Tullia Bruno, and Marie-Caroline Dieu-Nosjean) have developed a virtual seminar series through our new B cells in Cancer Consortium (BC^3) group. Check out the info and participate! #Bcells #Bcellsincancer <a href="/hollern_daniel/">Daniel Hollern</a>
Mara Gilardi (@gilardimara) 's Twitter Profile Photo

Please enjoy our new article highlighting the role of multi-omics and patient-relevant disease models in deciphering blood cancer complexity.